322 results
Page 4 of 17
8-K
EX-99.1
k9q0qmu1oivt
16 Jul 20
Bristol Myers Squibb Announces Expiration and Final Results of Registered Exchange Offers
8:30am
8-K
EX-99.1
31t1d3cytndig
16 Jun 20
Bristol Myers Squibb Announces Commencement of Registered Exchange Offers
8:39am
424B3
rdxh7on1
16 Jun 20
Prospectus supplement
8:01am
8-K
EX-99.1
h5io lxw0oyeci
7 May 20
Bristol Myers Squibb Reports Strong First Quarter 2020 Financial Results
8:08am
DEFA14A
9b137una5y6cyn0s
23 Apr 20
Additional proxy soliciting materials
8:59am
8-K
EX-99.1
sypzbkp
25 Mar 20
Other Events
9:15am
8-K
EX-99.1
nmn6x
6 Feb 20
Bristol-Myers Squibb Reports Fourth Quarter and Full Year Financial Results for 2019
8:20am
8-K/A
EX-99.1
klou6c8 xn9qdnsq18p
5 Feb 20
Report of Independent Registered Public Accounting Firm
4:42pm
8-K
EX-99.1
2t66y9su
31 Oct 19
Bristol-Myers Squibb Reports Third Quarter Financial Results
8:01am
8-K
EX-99.1
0jm60o hkkx
12 Sep 19
Bristol-Myers Squibb Board Announces Election of Three New Directors
5:27pm
8-K
xonai5jrt 7o3rb5
12 Sep 19
Bristol-Myers Squibb Board Announces Election of Three New Directors
5:27pm
8-K
EX-99.1
fyd q5s1zx9
26 Aug 19
Bristol-Myers Squibb Announces Agreement Between Celgene and Amgen to Divest OTEZLA® for $13.4 Billion
8:30am
8-K
EX-99.1
601oc3hxz5lpwn
25 Jul 19
Bristol-Myers Squibb Reports Second Quarter Financial Results
8:21am
8-K
EX-99.1
xv0n hr5msiiv9dly
5 Jun 19
Bristol-Myers Squibb Announces Post-Closing Leadership Team
8:24am
8-K
EX-99.1
m3kw n49vqj1fw2lvez6
1 May 19
Other Events
8:30am